Rationally reduced libraries for combinatorial pathway optimization minimizing experimental effort

Nature Communications

Volumn 7, Issue , 2016, Pages

  Jeschek, Markus ^a   Gerngross, Daniel ^a   Panke, Sven ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; BIOENGINEERING; DESIGN METHOD; ENZYME ACTIVITY; EXPERIMENTAL STUDY; METABOLISM; OPTIMIZATION; PIGMENT; PROTEIN;

BINDING SITE; BIOSYNTHESIS; COMBINATORIAL LIBRARY; HEURISTICS; LIBRARY; RIBOSOME; SCREENING; ALGORITHM; COMPUTER SIMULATION; METABOLIC ENGINEERING; METABOLISM; PROCEDURES;

INDOLE DERIVATIVE; VIOLACEIN;

ALGORITHMS; BINDING SITES; COMPUTER SIMULATION; INDOLES; METABOLIC ENGINEERING; METABOLIC NETWORKS AND PATHWAYS; RIBOSOMES;

EID: 84962816232     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms11163     Document Type: Article

References (50)

1. Canton, B., Labno, A., Endy, D. Refinement and standardization of synthetic biological parts and devices. Nat. Biotechnol. 26, 787-793 (2008).
2. Keasling, J. D. Manufacturing molecules through metabolic engineering. Science 330, 1355-1358 (2010).
3. Temme, K., Zhao, D. H., Voigt, C. A. Refactoring the nitrogen fixation gene cluster from Klebsiella oxytoca. Proc. Natl Acad. Sci. USA 109, 7085-7090 (2012).
4. Yokobayashi, Y., Weiss, R., Arnold, F. H. Directed evolution of a genetic circuit. Proc. Natl Acad. Sci. USA 99, 16587-16591 (2002).
5. Romero, P. A., Arnold, F. H. Exploring protein fitness landscapes by directed evolution. Nat. Rev. Mol. Cell Biol. 10, 866-876 (2009).
6. Du, J., Yuan, Y. B., Si, T., Lian, J. Z., Zhao, H. M. Customized optimization of metabolic pathways by combinatorial transcriptional engineering. Nucleic Acids Res. 40, e142 (2012).
7. Nowroozi, F. F. et al. Metabolic pathway optimization using ribosome binding site variants and combinatorial gene assembly. Appl. Microbiol. Biotechnol. 98, 1567-1581 (2014).
8. Smanski, M. J. et al. Functional optimization of gene clusters by combinatorial design and assembly. Nat. Biotechnol. 32, 1241-1249 (2014).
9. Latimer, L. N. et al. Employing a combinatorial expression approach to characterize xylose utilization in Saccharomyces cerevisiae. Metab. Eng. 25, 20-29 (2014).
10. Pitera, D. J., Paddon, C. J., Newman, J. D., Keasling, J. D. Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli. Metab. Eng. 9, 193-207 (2007).
11. Kittleson, J. T., Cheung, S., Anderson, J. C. Rapid optimization of gene dosage in E. coli using DIAL strains. J. Biol. Eng. 5, 10 (2011).
12. Alper, H., Fischer, C., Nevoigt, E., Stephanopoulos, G. Tuning genetic control through promoter engineering. Proc. Natl Acad. Sci. USA 102, 12678-12683 (2005).
13. Cox, R. S., Surette, M. G., Elowitz, M. B. Programming gene expression with combinatorial promoters. Mol. Syst. Biol. 3, 145 (2007).
14. Ellis, T.,Wang, X., Collins, J. J. Diversity-based, model-guided construction of synthetic gene networks with predicted functions. Nat. Biotechnol. 27, 465-471 (2009).
15. Welch, M. et al. Design parameters to control synthetic gene expression in Escherichia coli. PLoS ONE 4, e7002 (2009).
16. Welch, M., Villalobos, A., Gustafsson, C., Minshull, J. You're one in a googol: optimizing genes for protein expression. J. R. Soc. Interface 6, S467-S476 (2009).
17. Grilly, C., Stricker, J., Pang, W. L., Bennett, M. R., Hasty, J. A synthetic gene network for tuning protein degradation in Saccharomyces cerevisiae. Mol. Syst. Biol. 3, 127 (2007).
18. Zelcbuch, L. et al. Spanning high-dimensional expression space using ribosome-binding site combinatorics. Nucleic Acids Res. 41, e98 (2013).
19. Mutalik, V. K. et al. Precise and reliable gene expression via standard transcription and translation initiation elements. Nat. Methods 10, 354-360 (2013).
20. Salis, H. M., Mirsky, E. A., Voigt, C. A. Automated design of synthetic ribosome binding sites to control protein expression. Nat. Biotechnol. 27, 946-950 (2009).
21. Farasat, I. et al. Efficient search, mapping, and optimization of multi-protein genetic systems in diverse bacteria. Mol. Syst. Biol. 10, 731 (2014).
22. Laursen, B. S., Sorensen, H. P., Mortensen, K. K., Sperling-Petersen, H. U. Initiation of protein synthesis in bacteria. Microbiol. Mol. Biol. Rev. 69, 101-123 (2005)
23. Kudla, G., Murray, A. W., Tollervey, D., Plotkin, J. B. Coding-sequence determinants of gene expression in Escherichia coli. Science 324, 255-258 (2009).
24. Na, D., Lee, D. RBSDesigner: software for designing synthetic ribosome binding sites that yields a desired level of protein expression. Bioinformatics 26, 2633-2634 (2010).
25. Seo, S. W. et al. Predictive design of mRNA translation initiation region to control prokaryotic translation efficiency. Metab. Eng. 15, 67-74 (2013).
26. Borujeni, A. E., Channarasappa, A. S., Salis, H. M. Translation rate is controlled by coupled trade-offs between site accessibility, selective RNA unfolding and sliding at upstream standby sites. Nucleic Acids Res. 42, 2646-2659 (2014).
27. Reeve, B., Hargest, T., Gilbert, C., Ellis, T. Predicting translation initiation rates for designing synthetic biology. Front. Bioeng. Biotechnol. 2, 1 (2014).
28. Duran, M. et al. Potential applications of violacein: a microbial pigment. Med. Chem. Res. 21, 1524-1532 (2012).
29. Duran, N. et al. Violacein: properties and biological activities. Biotechnol. Appl. Biochem. 48, 127-133 (2007).
30. Ferreira, C. V. et al. Molecular mechanism of violacein-mediated human leukemia cell death. Blood 104, 1459-1464 (2004).
31. Reetz, M. T., Kahakeaw, D., Lohmer, R. Addressing the numbers problem in directed evolution. Chembiochem. 9, 1797-1804 (2008).
32. Mendes, A. S., de Carvalho, J. E., Duarte, M. C. T., Duran, N., Bruns, R. E. Factorial design and response surface optimization of crude violacein for Chromobacterium violaceum production. Biotechnol. Lett. 23, 1963-1969 (2001).
33. Balibar, C. J., Walsh, C. T. In vitro biosynthesis of violacein from L-tryptophan by the enzymes VioA-E from Chromobacterium violaceum. Biochemistry 45, 15444-15457 (2006).
34. Sanchez, C., Brana, A. F., Mendez, C., Salas, J. A. Reevaluation of the violacein biosynthetic pathway and its relationship to indolocarbazole biosynthesis. Chembiochem. 7, 1231-1240 (2006).
35. Rodrigues, A. L. et al. Microbial production of the drugs violacein and deoxyviolacein: analytical development and strain comparison. Biotechnol. Lett. 34, 717-720 (2012).
36. Rodrigues, A. L. et al. Systems metabolic engineering of Escherichia coli for production of the antitumor drugs violacein and deoxyviolacein. Metab. Eng. 20, 29-41 (2013).
37. Fang, M. Y. et al. High crude violacein production from glucose by Escherichia coli engineered with interactive control of tryptophan pathway and violacein biosynthetic pathway. Microb. Cell Fact. 14, 8 (2015).
38. Lee, M. E., Aswani, A., Han, A. S., Tomlin, C. J., Dueber, J. E. Expression-level optimization of a multi-enzyme pathway in the absence of a high-throughput assay. Nucleic Acids Res. 41, 10668-10678 (2013).
39. Kittleson, J. T., DeLoache, W., Cheng, H. Y., Anderson, J. C. Scalable plasmid transfer using engineered P1-based phagemids. ACS Syn. Biol. 1, 583-589 (2012).
40. Massey, F. J. The Kolmogorov-Smirnov test for goodness of fit. J. Am. Stat. Assoc. 46, 68-78 (1951).
41. Kaltenbach, H.-M. A Concise Guide to Statistics (Springer, 2012).
42. Albano, C. R., Randers-Eichhorn, L., Bentley, W. E., Rao, G. Green fluorescent protein as a real time quantitative reporter of heterologous protein production. Biotechnol. Prog. 14, 351-354 (1998).
43. Sambrook, J. F., Russell, D. W. Molecular Cloning : A Laboratory Manual 3rd edition (Cold Spring Harbor Laboratory, 2001).
44. Panke, S., Meyer, A., Huber, C. M., Witholt, B., Wubbolts, M. G. An alkane-responsive expression system for the production of fine chemicals. Appl. Environ. Microbiol. 65, 2324-2332 (1999).
45. Studier, F. W. Protein production by auto-induction in high-density shaking cultures. Protein Expr. Purif. 41, 207-234 (2005).
46. Silva-Rocha, R. et al. The Standard European Vector Architecture (SEVA): a coherent platform for the analysis and deployment of complex prokaryotic phenotypes. Nucleic Acids Res. 41, D666-D675 (2013).
47. Yanischperron, C., Vieira, J., Messing, J. Improved M13 phage cloning vectors and host strains-nucleotide-sequences of the M13mp18 and pUC19 vectors. Gene 33, 103-119 (1985).
48. Rosenberg, A. H. et al. Vectors for selective expression of cloned DNAs by T7 RNA-polymerase. Gene 56, 125-135 (1987).
49. Heckman, K. L., Pease, L. R. Gene splicing and mutagenesis by PCR-driven overlap extension. Nat. Protoc. 2, 924-932 (2007).
50. Fernandez, S., Delorenzo, V., Perezmartin, J. Activation of the transcriptional regulator XylR of Pseudomonas putida by release of repression between functional domains. Mol. Microbiol. 16, 205-213 (1995).